檢索結果 - Oliver Groß

Refine Results
  1. 1
    Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling

    Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling 由 Oliver Groß

    出版 2002
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

    Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies 由 Oliver Groß, Laura Perin, Constantinos Deltas

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    SGLT2 inhibitors: approved for adults and cats but not for children with CKD

    SGLT2 inhibitors: approved for adults and cats but not for children with CKD 由 Oliver Groß, Dieter Haffner, Franz Schaefer, Lutz T. Weber

    出版 2024
    獲取全文 獲取全文
    Editorial
    加到收藏夾
    Saved in:
  4. 4
    COVID-19-associated nephritis: early warning for disease severity and complications?

    COVID-19-associated nephritis: early warning for disease severity and complications? 由 Oliver Groß, Onnen Moerer, Manfred Weber, Tobias B. Huber, Simone Scheithauer

    出版 2020
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  5. 5
    Discoidin Domain Receptor 1 Protein Is a Novel Modulator of Megakaryocyte-Collagen Interactions

    Discoidin Domain Receptor 1 Protein Is a Novel Modulator of Megakaryocyte-Collagen Interactions 由 Vittorio Abbonante, Cristian Gruppi, Diana Rubel, Oliver Groß, Remigio Moratti, Alessandra Balduini

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome

    Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome 由 Oliver Groß, Michael H. Weber, Jochen W.U. Fries, G.A. Müller

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

    Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatr... 由 Oliver Groß, Tim Friede, Reinhard Hilgers, Anke Görlitz, Karsten Gavénis, Raees Ahmed, U Dürr

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy

    Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy 由 Judy Savige, Martin C. Gregory, Oliver Groß, Clifford E. Kashtan, Jie Ding, Frances Flinter

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss

    Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss 由 Mi Heon Ryu, Onkar P. Kulkarni, Ewa Radomska, Nicolai Miosge, Oliver Groß, Hans‐Joachim Anders

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1

    Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1 由 A. M. Meyer zum Gottesberge, Oliver Groß, Ursula Becker-Lendzian, Thomas Massing, Wolfgang F. Vogel

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis

    Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis 由 Oliver Groß, Eckhard Schulze-Lohoff, Marie-Louise Koepke, Bogdan Beirowski, Klaus Addicks, Wilhelm Bloch, Neil Smyth, M. Weber

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

    Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative 由 Clifford E. Kashtan, Jie Ding, Martin C. Gregory, Oliver Groß, Laurence Heidet, Bertrand Knebelmann, Michelle N. Rheault, Christoph Licht

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

    Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy 由 Christian D. Fankhauser, Sophia Sander, Lisa Roth, Oliver Gross, Daniel Eberli, Tullio Sulser, Burkhardt Seifert, J. Beyer, Thomas Hermanns

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome11See Editorial by Abbate and Remuzzi, p. 764.

    Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome11See Editorial by Abbate and Remuzzi, p. 764. 由 Oliver Groß, Bogdan Beirowski, Marie-Louise Koepke, Jeannine Kuck, Michael Reiner, Klaus Addicks, Neil Smyth, Eckhard Schulze-Lohoff, Manfred Weber

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice

    Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice 由 Volha Ninichuk, Oliver Groß, Stephan Segerer, Reinhard Hoffmann, Ewa Radomska, Andrea Buchstaller, Ralf Huss, Nese Akis, Detlef Schlöndorff, Hans‐Joachim Anders

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations

    Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations 由 Johanna Temme, Frederik Peters, Katharina Lange, Yves Pirson, Laurence Heidet, Roser Torrá, Jean‐Pierre Grünfeld, Manfred Weber, Christoph Licht, G. A. Müller, Oliver Groß

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group

    Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group 由 Clifford E. Kashtan, Jie Ding, Guido Garosi, Laurence Heidet, Laura Massella, Koichi Nakanishi, Kandai Nozu, Alessandra Renieri, Michelle N. Rheault, Fang Wang, Oliver Groß

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Lifelong effect of therapy in young patients with the <i>COL4A5</i> Alport missense variant p.(Gly624Asp): a prospective cohort study

    Lifelong effect of therapy in young patients with the <i>COL4A5</i> Alport missense variant p.(Gly624Asp): a prospective cohort study 由 Jan Boeckhaus, Julia Hoefele, Korbinian M. Riedhammer, Mato Nagel, Bodo B. Beck, Mira Choi, Maik Gollasch, Carsten Bergmann, Joseph Sonntag, Victoria Troesch, Johanna Stock, Oliver Groß

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport

    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport 由 Oliver Groß, Jan Boeckhaus, Lutz T. Weber, Hiddo J.L. Heerspink, James Simon, Rees Ahmed, Christoph Gerst, Ulrike Duerr, Florian Walker, Ralf Tostmann, Jürgen Helm, Thomas Asendorf, Tim Friede

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria

    DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria 由 Oliver Groß, Bogdan Beirowski, Scott J. Harvey, Catherine McFadden, Dilys Chen, Stephanie Tam, Paul S. Thorner, Neil Smyth, Klaus Addicks, Wilhelm Bloch, Yoshifumi Ninomiya, Yoshikazu Sado, Manfred Weber, Wolfgang F. Vogel

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: